Commentary & Opinion
Lancet Comment Says HIV Treatment Needs Continued Scale-Up
August 6, 2010
Keying off a Lancet study on how prognostic modeling might help guide antiretroviral therapy in sub-Saharan Africa, the authors of a Lancet Comment write about the "enormous" challenge of treating all HIV-positive patients in need of drugs and the importance of gaining efficiencies in overall health care in developing countries. "There is a growing pessimism among donors about how to deal with the difficulty of HIV treatment in resource-poor settings. There is a move towards control of other diseases with less expensive therapies that are time-restricted and strengthening of health systems instead of provision of antiretrovirals. Funding for HIV treatment should again be put on the international agenda otherwise the efforts of the past will have been in vain," the authors write (Koole/Colebunders, 8/7).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)